Suboxone: Rationale, Science, Misconceptions. - sprookjes - yvandenbroek - TriplyDB

Suboxone: Rationale, Science, Misconceptions.

Suboxone: Rationale, Science, Misconceptions.

http://www.wikidata.org/entity/Q52645984

about

Suboxone: Rationale, Science, Misconceptions.

http://www.wikidata.org/entity/Q52645984

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Suboxone: Rationale, Science, Misconceptions.

@en

Suboxone: Rationale, Science, Misconceptions.

@nl

type

label

Suboxone: Rationale, Science, Misconceptions.

@en

Suboxone: Rationale, Science, Misconceptions.

@nl

prefLabel

Suboxone: Rationale, Science, Misconceptions.

@en

Suboxone: Rationale, Science, Misconceptions.

@nl

P1433

Q52645984-40E3DF7D-4C13-419A-9D3B-30065E74A220

P1476

Q52645984-AA479D5F-105C-44FB-83CE-CD9E4BA5B0A9

P2093

Q52645984-676A0652-4FAF-413D-9AC8-2460EBA4771B

P2860

Q52645984-026C2545-C198-47D6-B2D4-67F4FF8DC12C

Q52645984-0898F207-22CF-4360-958E-E80FAF64484A

Q52645984-095D8933-3699-4FA1-815F-9296FC0CC39B

Q52645984-0D908BBA-8832-44DA-B45B-74CDAD203722

Q52645984-0F81CB0F-4817-43F8-BFDD-2E707C137CD7

Q52645984-19C71206-E531-42A1-A579-560436FF163F

Q52645984-1AE3AB79-A3CC-41E3-BBE4-7E5792138858

Q52645984-1BC0B691-7F71-49E4-A3DE-AEBD9AF6F582

Q52645984-2717841A-1F76-4142-B45A-FEB696E8E598

Q52645984-298F5E0E-9269-4879-81EC-DE173457CA69

P304

Q52645984-7EA96F60-794E-4F6E-A25D-59A74456FD24

P31

Q52645984-9AB1E540-860C-4779-9166-0D0A1CA88E19

P433

Q52645984-3339F105-D2B4-4610-9954-4A03F33A04F4

P478

Q52645984-51A2A08D-8EB8-4F3F-92D5-324C5C9F1C25

P577

Q52645984-67E48D19-A334-4A48-9A56-F68CEFD39EE4

P698

Q52645984-2876A525-64D4-461F-92F0-682C5EEA546F

P932

Q52645984-F98F6631-1CF7-4AA3-A3D8-001B5230925A

P1433

The Ochsner journal

P1476

Suboxone: Rationale, Science, Misconceptions.

@en

P2093

Jennifer R Velander

http://www.w3.org/2001/XMLSchema#string

P2860

Opioid agonist treatment for pharmaceutical opioid dependent people

Oral substitution treatment of injecting opioid users for prevention of HIV infection

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?

Factors affecting willingness to provide buprenorphine treatment.

P304

23-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29559865

http://www.w3.org/2001/XMLSchema#string

P932

5855417

http://www.w3.org/2001/XMLSchema#string